Fibrosarcomas are relatively common in cats. It is of utmost importance to differentiate vaccine or injection site-associated sarcoma (VAS) from non-vaccine-associated sarcoma as the prognosis and treatment strategies for each type differ significantly. In this webcast, Dr. Philip J. Bergman will focus on the history, possible impact from adjuvant vs. not, diagnosis, prognosis, and therapy of cats with VAS.
Join us as we discuss strategies to help veterinary teams manage this condition effectively.